Please wait a moment . . .

 

Neutral theory via the Jandhyala method

May 22, 20220
jandhyala method

We @Medialis Ltd are pleased to share with you the second of a series of updates on the #medicalaffairs principles underlying our work, the four pillars of our medical #thirty22RWEstrategy in the #pharmaceuticalindustry, #rarediseases and #orphandrugs.

Pillar 2 of our strategy focuses on the application of #Neutraltheory via the #Jandhyalamethod to observe #consensusopinion from #keyopinionleaders to answer #listgeneratingquestions, improving the accuracy of #constructmeasurement in #clinicaltrials and #clinicalstudies.

The Jandhyala method is distinct from Delphi and modified Delphi methods, as it allows us to observe experts’ existing awareness of a topic, providing a measure of the reliability of the opinion, and the consensus rate of each list item, allowing us to quantify the integrity of the opinion and deal with list items differently.

Our current #corporatesocialresponsibility programme is applying the Jandhyala method to disease-specific #QualityofLife measures, the development of #patientregistries in rare diseases and the characterisation of #medicalaffairspharmaceuticalphysician cancel culture within the #pharmaceuticalindustry.

Contact Medialis Ltd to find out how the Jandhyala method can observe consensus opinion and enhance construct measurement for your #patientgroup and new #medicine.

#medicalaffairs #pharmaceuticals #clinicalresearch #rwe #raredisease

Leave a Reply

Your email address will not be published. Required fields are marked *